pamidronate has been researched along with Hypoparathyroidism in 8 studies
Hypoparathyroidism: A condition caused by a deficiency of PARATHYROID HORMONE (or PTH). It is characterized by HYPOCALCEMIA and hyperphosphatemia. Hypocalcemia leads to TETANY. The acquired form is due to removal or injuries to the PARATHYROID GLANDS. The congenital form is due to mutations of genes, such as TBX1; (see DIGEORGE SYNDROME); CASR encoding CALCIUM-SENSING RECEPTOR; or PTH encoding parathyroid hormone.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A 62-yr-old woman with thyroid carcinoma metastatic to bone, and a history of subclinical hypoparathyroidism was admitted to the hospital in hypocalcemic crisis 5 wk after receiving iv pamidronate." | 7.71 | Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism. ( Jonklaas, J; Mishra, A; Wong, L, 2001) |
| "Pamidronate is an effective drug used not only in patients with tumor-associated hypercalcemia, but also in normocalcemic patients with metastatic bone disease to relieve pains." | 5.30 | Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate. ( Alakavuklar, M; Biberoglu, S; Cömlekçi, A; Hekimsoy, Z; Okan, I; Pişkin, O; Sekeroglu, B, 1998) |
| "A 62-yr-old woman with thyroid carcinoma metastatic to bone, and a history of subclinical hypoparathyroidism was admitted to the hospital in hypocalcemic crisis 5 wk after receiving iv pamidronate." | 3.71 | Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism. ( Jonklaas, J; Mishra, A; Wong, L, 2001) |
| " This article presents a patient with hypoparathyroidism who was treated with calcium carbonate and calcitriol resulting in two admissions to the hospital for milk-alkali syndrome." | 3.69 | Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism. ( Powers, K; Tal, A, 1996) |
| "Pamidronate is an effective drug used not only in patients with tumor-associated hypercalcemia, but also in normocalcemic patients with metastatic bone disease to relieve pains." | 1.30 | Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate. ( Alakavuklar, M; Biberoglu, S; Cömlekçi, A; Hekimsoy, Z; Okan, I; Pişkin, O; Sekeroglu, B, 1998) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 3 (37.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boumans, D | 1 |
| de Vries, PA | 1 |
| Rikken, NE | 1 |
| Laverman, GD | 1 |
| Pittaway, JF | 1 |
| Srirangalingam, U | 1 |
| Hanson, PL | 1 |
| Jones, P | 1 |
| Drake, WM | 1 |
| Loupy, A | 1 |
| Ramakrishnan, SK | 1 |
| Wootla, B | 1 |
| Chambrey, R | 1 |
| de la Faille, R | 1 |
| Bourgeois, S | 1 |
| Bruneval, P | 1 |
| Mandet, C | 1 |
| Christensen, EI | 1 |
| Faure, H | 1 |
| Cheval, L | 1 |
| Laghmani, K | 1 |
| Collet, C | 1 |
| Eladari, D | 1 |
| Dodd, RH | 1 |
| Ruat, M | 1 |
| Houillier, P | 1 |
| Kato, A | 1 |
| Shinozaki, S | 1 |
| Goga, T | 1 |
| Hishida, A | 1 |
| Tal, A | 1 |
| Powers, K | 1 |
| Cömlekçi, A | 1 |
| Biberoglu, S | 1 |
| Hekimsoy, Z | 1 |
| Okan, I | 1 |
| Pişkin, O | 1 |
| Sekeroglu, B | 1 |
| Alakavuklar, M | 1 |
| Mishra, A | 1 |
| Wong, L | 1 |
| Jonklaas, J | 1 |
| Stuckey, BG | 1 |
| Lim, EM | 1 |
| Kent, GN | 1 |
| Ward, LC | 1 |
| Gutteridge, DH | 1 |
8 other studies available for pamidronate and Hypoparathyroidism
| Article | Year |
|---|---|
Prolonged hypocalcaemia after pamidronate infusion in Riedel's thyroiditis associated hypoparathyroidism.
Topics: Bone Density Conservation Agents; Calcium Carbonate; Dihydrotachysterol; Diphosphonates; Female; Gas | 2013 |
Renal replacement therapy as a treatment for severe refractory hypercalcemia.
Topics: Adenoma; Adult; Carcinoma; Cinacalcet; Diphosphonates; Drug Resistance; Emergencies; Female; Furosem | 2014 |
PTH-independent regulation of blood calcium concentration by the calcium-sensing receptor.
Topics: Amino Acids; Animals; Bone Density Conservation Agents; Calcium; Creatinine; Diphosphonates; Hypopar | 2012 |
Isolated adrenocorticotropic hormone deficiency presenting with hypercalcemia in a patient on long-term hemodialysis.
Topics: Adrenal Insufficiency; Adrenocorticotropic Hormone; Adult; Calcitriol; Corticotropin-Releasing Hormo | 2003 |
Milk-alkali syndrome induced by 1,25(OH)2D in a patient with hypoparathyroidism.
Topics: Aged; Anti-Inflammatory Agents; Calcitriol; Calcium Carbonate; Diphosphonates; Emergencies; Female; | 1996 |
Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate.
Topics: Adult; Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Calcium; Carcinoma; Diphosphonates; | 1998 |
Prolonged, symptomatic hypocalcemia with pamidronate administration and subclinical hypoparathyroidism.
Topics: Antineoplastic Agents; Bone Neoplasms; Calcitonin; Calcium Carbonate; Diphosphonates; Female; Humans | 2001 |
Bisphosphonate therapy for Paget's disease in a patient with hypoparathyroidism: profound hypocalcemia, rapid response, and prolonged remission.
Topics: Alendronate; Calcitriol; Calcium; Cervical Vertebrae; Diphosphonates; Female; Humans; Hypocalcemia; | 2001 |